Global Gases for Pharmaceutical and Biotechnology Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Gases for Pharmaceutical and Biotechnology Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

According to APO Research, The global Gases for Pharmaceutical and Biotechnology market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Gases for Pharmaceutical and Biotechnology include Air Liquide, Taiyo Nippon Sanso, Messer Group, Matheson, Air Products, Coregas, Linde and SOL Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gases for Pharmaceutical and Biotechnology, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Gases for Pharmaceutical and Biotechnology, also provides the sales of main regions and countries. Of the upcoming market potential for Gases for Pharmaceutical and Biotechnology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gases for Pharmaceutical and Biotechnology sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Gases for Pharmaceutical and Biotechnology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Gases for Pharmaceutical and Biotechnology sales, projected growth trends, production technology, application and end-user industry.

Gases for Pharmaceutical and Biotechnology segment by Company

Air Liquide
Taiyo Nippon Sanso
Messer Group
Matheson
Air Products
Coregas
Linde
SOL Group

Gases for Pharmaceutical and Biotechnology segment by Type

Nitrogen
Carbon Dioxide
Oxygen
Others

Gases for Pharmaceutical and Biotechnology segment by Application

Laboratory
Pharmaceutical and Biotechnology Companies
Others

Gases for Pharmaceutical and Biotechnology segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Gases for Pharmaceutical and Biotechnology status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Gases for Pharmaceutical and Biotechnology market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gases for Pharmaceutical and Biotechnology significant trends, drivers, influence factors in global and regions.
6. To analyze Gases for Pharmaceutical and Biotechnology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gases for Pharmaceutical and Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gases for Pharmaceutical and Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gases for Pharmaceutical and Biotechnology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gases for Pharmaceutical and Biotechnology market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gases for Pharmaceutical and Biotechnology industry.
Chapter 3: Detailed analysis of Gases for Pharmaceutical and Biotechnology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Gases for Pharmaceutical and Biotechnology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Gases for Pharmaceutical and Biotechnology in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Gases for Pharmaceutical and Biotechnology Sales Value (2019-2030)
1.2.2 Global Gases for Pharmaceutical and Biotechnology Sales Volume (2019-2030)
1.2.3 Global Gases for Pharmaceutical and Biotechnology Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Gases for Pharmaceutical and Biotechnology Market Dynamics
2.1 Gases for Pharmaceutical and Biotechnology Industry Trends
2.2 Gases for Pharmaceutical and Biotechnology Industry Drivers
2.3 Gases for Pharmaceutical and Biotechnology Industry Opportunities and Challenges
2.4 Gases for Pharmaceutical and Biotechnology Industry Restraints
3 Gases for Pharmaceutical and Biotechnology Market by Company
3.1 Global Gases for Pharmaceutical and Biotechnology Company Revenue Ranking in 2023
3.2 Global Gases for Pharmaceutical and Biotechnology Revenue by Company (2019-2024)
3.3 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Company (2019-2024)
3.4 Global Gases for Pharmaceutical and Biotechnology Average Price by Company (2019-2024)
3.5 Global Gases for Pharmaceutical and Biotechnology Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Gases for Pharmaceutical and Biotechnology Company Manufacturing Base & Headquarters
3.7 Global Gases for Pharmaceutical and Biotechnology Company, Product Type & Application
3.8 Global Gases for Pharmaceutical and Biotechnology Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Gases for Pharmaceutical and Biotechnology Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Gases for Pharmaceutical and Biotechnology Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Gases for Pharmaceutical and Biotechnology Market by Type
4.1 Gases for Pharmaceutical and Biotechnology Type Introduction
4.1.1 Nitrogen
4.1.2 Carbon Dioxide
4.1.3 Oxygen
4.1.4 Others
4.2 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Type
4.2.1 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Type (2019-2030)
4.2.3 Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Type (2019-2030)
4.3 Global Gases for Pharmaceutical and Biotechnology Sales Value by Type
4.3.1 Global Gases for Pharmaceutical and Biotechnology Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Gases for Pharmaceutical and Biotechnology Sales Value by Type (2019-2030)
4.3.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type (2019-2030)
5 Gases for Pharmaceutical and Biotechnology Market by Application
5.1 Gases for Pharmaceutical and Biotechnology Application Introduction
5.1.1 Laboratory
5.1.2 Pharmaceutical and Biotechnology Companies
5.1.3 Others
5.2 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Application
5.2.1 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Gases for Pharmaceutical and Biotechnology Sales Volume by Application (2019-2030)
5.2.3 Global Gases for Pharmaceutical and Biotechnology Sales Volume Share by Application (2019-2030)
5.3 Global Gases for Pharmaceutical and Biotechnology Sales Value by Application
5.3.1 Global Gases for Pharmaceutical and Biotechnology Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Gases for Pharmaceutical and Biotechnology Sales Value by Application (2019-2030)
5.3.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application (2019-2030)
6 Gases for Pharmaceutical and Biotechnology Market by Region
6.1 Global Gases for Pharmaceutical and Biotechnology Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Gases for Pharmaceutical and Biotechnology Sales by Region (2019-2030)
6.2.1 Global Gases for Pharmaceutical and Biotechnology Sales by Region: 2019-2024
6.2.2 Global Gases for Pharmaceutical and Biotechnology Sales by Region (2025-2030)
6.3 Global Gases for Pharmaceutical and Biotechnology Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Gases for Pharmaceutical and Biotechnology Sales Value by Region (2019-2030)
6.4.1 Global Gases for Pharmaceutical and Biotechnology Sales Value by Region: 2019-2024
6.4.2 Global Gases for Pharmaceutical and Biotechnology Sales Value by Region (2025-2030)
6.5 Global Gases for Pharmaceutical and Biotechnology Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Gases for Pharmaceutical and Biotechnology Sales Value (2019-2030)
6.6.2 North America Gases for Pharmaceutical and Biotechnology Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Gases for Pharmaceutical and Biotechnology Sales Value (2019-2030)
6.7.2 Europe Gases for Pharmaceutical and Biotechnology Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Gases for Pharmaceutical and Biotechnology Sales Value (2019-2030)
6.8.2 Asia-Pacific Gases for Pharmaceutical and Biotechnology Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Gases for Pharmaceutical and Biotechnology Sales Value (2019-2030)
6.9.2 Latin America Gases for Pharmaceutical and Biotechnology Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Gases for Pharmaceutical and Biotechnology Sales Value (2019-2030)
6.10.2 Middle East & Africa Gases for Pharmaceutical and Biotechnology Sales Value Share by Country, 2023 VS 2030
7 Gases for Pharmaceutical and Biotechnology Market by Country
7.1 Global Gases for Pharmaceutical and Biotechnology Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Gases for Pharmaceutical and Biotechnology Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Gases for Pharmaceutical and Biotechnology Sales by Country (2019-2030)
7.3.1 Global Gases for Pharmaceutical and Biotechnology Sales by Country (2019-2024)
7.3.2 Global Gases for Pharmaceutical and Biotechnology Sales by Country (2025-2030)
7.4 Global Gases for Pharmaceutical and Biotechnology Sales Value by Country (2019-2030)
7.4.1 Global Gases for Pharmaceutical and Biotechnology Sales Value by Country (2019-2024)
7.4.2 Global Gases for Pharmaceutical and Biotechnology Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.5.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.6.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.7.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.8.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.9.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.10.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.11.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.12.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.13.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.14.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.15.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.16.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.17.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.18.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.19.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.20.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.21.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.22.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Gases for Pharmaceutical and Biotechnology Sales Value Growth Rate (2019-2030)
7.23.2 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Gases for Pharmaceutical and Biotechnology Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Air Liquide
8.1.1 Air Liquide Comapny Information
8.1.2 Air Liquide Business Overview
8.1.3 Air Liquide Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2019-2024)
8.1.4 Air Liquide Gases for Pharmaceutical and Biotechnology Product Portfolio
8.1.5 Air Liquide Recent Developments
8.2 Taiyo Nippon Sanso
8.2.1 Taiyo Nippon Sanso Comapny Information
8.2.2 Taiyo Nippon Sanso Business Overview
8.2.3 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2019-2024)
8.2.4 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Product Portfolio
8.2.5 Taiyo Nippon Sanso Recent Developments
8.3 Messer Group
8.3.1 Messer Group Comapny Information
8.3.2 Messer Group Business Overview
8.3.3 Messer Group Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2019-2024)
8.3.4 Messer Group Gases for Pharmaceutical and Biotechnology Product Portfolio
8.3.5 Messer Group Recent Developments
8.4 Matheson
8.4.1 Matheson Comapny Information
8.4.2 Matheson Business Overview
8.4.3 Matheson Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2019-2024)
8.4.4 Matheson Gases for Pharmaceutical and Biotechnology Product Portfolio
8.4.5 Matheson Recent Developments
8.5 Air Products
8.5.1 Air Products Comapny Information
8.5.2 Air Products Business Overview
8.5.3 Air Products Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2019-2024)
8.5.4 Air Products Gases for Pharmaceutical and Biotechnology Product Portfolio
8.5.5 Air Products Recent Developments
8.6 Coregas
8.6.1 Coregas Comapny Information
8.6.2 Coregas Business Overview
8.6.3 Coregas Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2019-2024)
8.6.4 Coregas Gases for Pharmaceutical and Biotechnology Product Portfolio
8.6.5 Coregas Recent Developments
8.7 Linde
8.7.1 Linde Comapny Information
8.7.2 Linde Business Overview
8.7.3 Linde Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2019-2024)
8.7.4 Linde Gases for Pharmaceutical and Biotechnology Product Portfolio
8.7.5 Linde Recent Developments
8.8 SOL Group
8.8.1 SOL Group Comapny Information
8.8.2 SOL Group Business Overview
8.8.3 SOL Group Gases for Pharmaceutical and Biotechnology Sales, Value and Gross Margin (2019-2024)
8.8.4 SOL Group Gases for Pharmaceutical and Biotechnology Product Portfolio
8.8.5 SOL Group Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Gases for Pharmaceutical and Biotechnology Value Chain Analysis
9.1.1 Gases for Pharmaceutical and Biotechnology Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Gases for Pharmaceutical and Biotechnology Sales Mode & Process
9.2 Gases for Pharmaceutical and Biotechnology Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Gases for Pharmaceutical and Biotechnology Distributors
9.2.3 Gases for Pharmaceutical and Biotechnology Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings